Stay updated on Zenocutuzumab Clinical Trial in NRG1 Fusion
Sign up to get notified when there's something new on the Zenocutuzumab Clinical Trial in NRG1 Fusion page.

Latest updates to the Zenocutuzumab Clinical Trial in NRG1 Fusion page
- CheckyesterdayChange DetectedA site-wide banner announces changes to NIH terminology and links to transition updates and FAQs.SummaryDifference1%

- Check8 days agoChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2, while the study record page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe page now shows a 403 Forbidden message instead of the full study content. This blocks access to core study details, eligibility criteria, locations, and related information previously visible on the record.SummaryDifference19%

- Check56 days agoChange DetectedAdded a new funding reference '2014 ( U.S. NIH Grant/Contract )' to the study identifiers and updated the revision tag to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check78 days agoChange DetectedThe revision label updated from v3.6.4 to v3.6.5, indicating a newer version of the study page. This signals minor maintenance or content refresh rather than changes to the study data.SummaryDifference0.0%

Stay in the know with updates to Zenocutuzumab Clinical Trial in NRG1 Fusion
Enter your email address, and we'll notify you when there's something new on the Zenocutuzumab Clinical Trial in NRG1 Fusion page.